Hemophilia is a rare genetic bleeding disorder characterized by the deficiency of specific clotting factors, which impairs the body’s ability to stop bleeding. Individuals with hemophilia are at risk of prolonged bleeding after injuries, surgeries, or even spontaneous bleeding episodes, particularly in the joints and muscles. Advances in hemophilia medicine have revolutionized patient care through the development of factor replacement therapies, which provide the missing clotting factors and help prevent and treat bleeding episodes. Innovative approaches, such as gene therapy, are also emerging, offering the potential for long-term management and even a cure. Ongoing research continues to enhance understanding of hemophilia and improve treatment strategies, enabling individuals with this condition to lead healthier, more active lives.
|
|
|
|
